Viewing Study NCT01772212


Ignite Creation Date: 2025-12-26 @ 11:13 PM
Ignite Modification Date: 2025-12-26 @ 11:13 PM
Study NCT ID: NCT01772212
Status: COMPLETED
Last Update Posted: 2017-06-22
First Post: 2013-01-17
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Bioequivalence Study for Terbinafine 250 mg
Sponsor: GlaxoSmithKline
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module